A NEJM study estimates that 2 percent of all cancers in the next 20 to 30 years may be attributable to CT scans.
The price of overtesting and defensive medicine has just gone up.
More testing does not always equate to better medicine.
A NEJM study estimates that 2 percent of all cancers in the next 20 to 30 years may be attributable to CT scans.
The price of overtesting and defensive medicine has just gone up.
More testing does not always equate to better medicine.
Get free updates delivered free to your inbox.
Comments are moderated before they are published. Please read the comment policy.